Actively Recruiting
Effectiveness of a Wearable Device and AI-Supported Diet and Exercise Intervention in Obese Adults A Quasi-experimental Design Study
Led by National Taiwan University Hospital · Updated on 2026-03-25
120
Participants Needed
2
Research Sites
50 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are studying overweight and obese adults to evaluate the effectiveness of a 6-month personalized diet and exercise program aimed at promoting weight loss. This study focuses on different obesity levels and examines the role of galectin-1, a protein linked to inflammation and fat tissue, in relation to weight loss and metabolic changes. The research compares standard care with an intervention using wearable devices and artificial intelligence (AI) apps to support lifestyle changes. Participants are divided into two groups: one follows a standard diet and exercise program based on Mediterranean diet principles and physical activity guidelines, while the other group uses wearable devices and AI apps alongside the same program. The devices track steps, heart rate, and calories burned, and participants log their food intake using a smartphone app. The program includes outpatient visits at weeks 0, 12, and 24, with phone consultations at weeks 2, 4, and 8 to provide coaching and guidance. Weight loss medications are not allowed during the study. During the study, researchers measure participants' weight, height, blood pressure, waist circumference, body composition, and blood samples to assess glucose, cholesterol, triglycerides, insulin, and galectin-1 levels. Measurements are taken at the start and at week 24. Participants receive diet and exercise education, and case managers offer coaching through a health management platform. The main outcome measured is weight change after 24 weeks, along with secondary outcomes like waist size, blood pressure, and cholesterol levels.
CONDITIONS
Brief Title
A Wearable Device and AI-Supported Diet and Exercise Intervention
Who Can Participate
Eligibility Criteria
You may qualify if you...
- At least 20 years of age
- Body mass index (BMI) of 24 kg/m2 or higher with one or more obesity-related conditions such as hypertension, diabetes, hyperlipidemia, sleep apnea syndrome, or nonalcoholic fatty liver disease
- Ability to use a wearable device and a smartphone app
- Ability to sign the informed consent form after receiving detailed study information
You will not qualify if you...
- Unable to complete self-administered questionnaires
- Unable to complete body composition assessments, hand grip test, or blood sampling
- Unable to attend scheduled clinic visits
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 6 months
Participants engage in a 6-month diet and exercise program. Some use a wearable device and AI-supported app to track their activity and diet, while others follow a standard diet and exercise plan. They receive face-to-face diet and exercise education and coaching from case managers.
3 outpatient clinic visits at week 0, week 12, and week 24, plus phone consultations at week 2, week 4, and week 8
Trial Site Locations
Total: 2 locations
1
National Taiwan University Hospital
Taipei, Taipei, Taiwan, 100
Actively Recruiting
2
National Taiwan University Hospital
Taipei, Taiwan, 100
Actively Recruiting
Research Team
C
CW LU, A.P.
K
KC Huang, Professor
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here